[Effect of antiplatelet therapy on prevention of thrombotic diseases].
Mase
K
K
Yasunaga
K
K
D016718:Arachidonic Acid / Q000378:metabolism; D001157:Arterial Occlusive Diseases / Q000517:prevention & control; D001241:Aspirin / Q000494:pharmacology / Q000627:therapeutic use; D002544:Cerebral Infarction / Q000517:prevention & control; D006801:Humans; D009203:Myocardial Infarction / Q000517:prevention & control; D009712:Nucleotides, Cyclic / Q000378:metabolism; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D011982:Receptors, Prostaglandin / Q000037:antagonists & inhibitors; D017482:Receptors, Thromboxane; D012008:Recurrence; D013927:Thrombosis / Q000517:prevention & control*
D009712:Nucleotides, Cyclic; D010975:Platelet Aggregation Inhibitors; D011982:Receptors, Prostaglandin; D017482:Receptors, Thromboxane; D016718:Arachidonic Acid; D001241:Aspirin